Correlation Between Tff Pharmaceuticals and Emergent Biosolutions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Emergent Biosolutions, you can compare the effects of market volatilities on Tff Pharmaceuticals and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Emergent Biosolutions.

Diversification Opportunities for Tff Pharmaceuticals and Emergent Biosolutions

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tff and Emergent is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between Tff Pharmaceuticals and Emergent Biosolutions

Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Tff Pharmaceuticals is 1.09 times less risky than Emergent Biosolutions. The stock trades about -0.07 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,206  in Emergent Biosolutions on September 3, 2024 and sell it today you would lose (194.00) from holding Emergent Biosolutions or give up 16.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tff Pharmaceuticals  vs.  Emergent Biosolutions

 Performance 
       Timeline  
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Emergent Biosolutions 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Tff Pharmaceuticals and Emergent Biosolutions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tff Pharmaceuticals and Emergent Biosolutions

The main advantage of trading using opposite Tff Pharmaceuticals and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.
The idea behind Tff Pharmaceuticals and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data